Navigation Links
Functional Regeneration of the Macula with Autologous Stem Cells
Date:7/30/2013

QUERETARO, Mexico, July 30, 2013 /PRNewswire/ -- The company CELLMAK is dedicated to biomedical research in regenerative cellular medicine and tissue engineering with a group of scientists led by Biomedical Researcher Mario Camacho.

Five years ago we began our work on clinical research protocols for the functional Regeneration of the Retina, working with cases of Age-related Macular, Glaucoma and Optic Nerve Atrophy, using autologous stem cells from bone marrow with excellent results.  In other countries, at present they are only in the initial clinical research protocols for these ailments. 

We do not commercialize treatments, but since we do not have support from the government or large companies, patients, who are evaluated by the ophthalmologists we work with as viable candidates for our protocols, pay out of their own pockets for the inputs and medical fees involved. 

We Mexicans are proud to be competing with research groups from all over the world, many of them endowed with multi-million dollar support from their governments or major corporations.  

CELLMAK has distinguished itself as the first company in Latin America successfully to introduce Cellular Facial Rejuvenation to the market, using the patient's own fatty tissue cells, and without surgery! 

We are located in the city of Queretaro, one of the safest and most beautiful cities in Mexico, where people come to see us from all over the world. 

Our protocols depend on COFEPRIS, Mexico's regulatory agency for health matters.  At present the FDA has no role whatsoever in regulating us.  

CELLMAK is a company founded by Biomedical Researcher Mario Camacho and his wife, Karyna Camacho, who have worked indefatigably to create the technology and appropriate standards for the application of autologous stem cells (that is, using the patient's own stem cells) for Mexico and the world.

At CELLMAK we work to improve the quality of people's lives, and are putting Mexico in first place, competing at the global level in the generation of new technology. 

Make an appointment now and find out how you can participate in our clinical research protocols.

Mario Camacho is a Biomedical Researcher engaged in comprehensive handling of autologous stem cells, and he works with medical specialists who clinically evaluate viable candidates and deal directly with the patients.

Contact information:

https://www.facebook.com/Cellmak 
e-mail: celulasmadre1@aol.com 
Phone: (52) 442 2200546 and 442 2452997
also soon at: www.cellmak.com


'/>"/>
SOURCE CELLMAK
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
2. Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment
3. Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act Like Younger Cells
4. Researchers build functional ovarian tissue in lab
5. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
6. ALCAT Pioneer, Roger Deutsch, to Address "Food Allergies and Intolerances" at the Institute of Functional Medicine Conference in Tampa, February 8-10
7. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
8. New structural information on functionalization of gold nanoparticles
9. Baylor College of Medicine and Gradalis Enter Collaboration Agreement to Utilize Gradalis Bifunctional shRNA Platform in Translational Medicine Research
10. RURO Adds Critical Level Monitoring Functionality to its Inventory Management Software FreezerPro.
11. Seahorse Launches Reagent to Make Functional Fatty Acid Oxidation (FAO) Assays Easy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... -- Global demand for enzymes is forecast to grow ... billion.  This market includes enzymes used in industrial ... animal feed, and other markets) and specialty applications ... beverages will remain the largest market for enzymes, ... containing enzymes in developing regions.  These and other ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... published their findings on what they believe could be a new and helpful ... the new research. Click here to read it now. , Biomarkers ...
(Date:6/27/2016)... ... June 27, 2016 , ... Rolf K. Hoffmann, former senior ... the University of North Carolina Kenan-Flagler Business School effective June 27. ... Kenan-Flagler, with a focus on the school’s international efforts, leading classes and participating ...
(Date:6/24/2016)... discussions on a range of subjects including policies, debt and ... Poloz. Speaking at a lecture to the Canadian ... to the country,s inflation target, which is set by both ... "In certain areas there needs to be ... why not sit down and address strategy together?" ...
Breaking Biology Technology:
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... The new GEZE SecuLogic access ... "all-in-one" system solution for all door components. It can ... door interface with integration authorization management system, and thus ... minimal dimensions of the access control and the optimum ... offer considerable freedom of design with regard to the ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
Breaking Biology News(10 mins):